We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.91B
AUM Growth
+$396M
Cap. Flow
+$287M
Cap. Flow %
15.09%
Top 10 Hldgs %
22.25%
Holding
1,595
New
496
Increased
417
Reduced
319
Closed
313

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$12.1M
2
BMBL icon
Bumble
BMBL
+$11.4M
3
NVDA icon
NVIDIA
NVDA
+$10M
4
MRCY icon
Mercury Systems
MRCY
+$6.22M
5
HUM icon
Humana
HUM
+$6.18M

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$14M
2
BEKE icon
KE Holdings
BEKE
+$12.7M
3
BABA icon
Alibaba
BABA
+$11.4M
4
SPLK
Splunk Inc
SPLK
+$11.1M
5
LI icon
Li Auto
LI
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Consumer Discretionary 10.36%
3 Healthcare 9.86%
4 Industrials 9.74%
5 Energy 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMLS
1226
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$76.9K ﹤0.01%
21,413
– –
SAVE
1227
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$76K ﹤0.01%
+15,700
New +$116K
ESPR
1228
DELISTED
Esperion Therapeutics
ESPR
$74.9K ﹤0.01%
27,963
-1,828
-6% -$4.44K
SLQT icon
1229
SelectQuote
SLQT
$126M
$74K ﹤0.01%
+37,025
New +$55.4K
BCOV
1230
DELISTED
Brightcove, Inc.
BCOV
$70.2K ﹤0.01%
36,168
+3,368
+10% +$7.39K
HBIO icon
1231
Harvard Bioscience
HBIO
$29.1M
$70.1K ﹤0.01%
1,653
– –
OPAL icon
1232
OPAL Fuels
OPAL
$80.8M
$70.1K ﹤0.01%
13,960
+3,609
+35% +$17.7K
VIGL
1233
DELISTED
Vigil Neuroscience
VIGL
$69.5K ﹤0.01%
+20,377
New +$63.6K
SRTA
1234
Strata Critical Medical Inc
SRTA
$516M
$68.7K ﹤0.01%
+24,100
New +$74.4K
PACB icon
1235
Pacific Biosciences
PACB
$351M
$66.9K ﹤0.01%
17,850
-2,309
-11% -$13.5K
AMRX icon
1236
Amneal Pharmaceuticals
AMRX
$5.79B
$65.7K ﹤0.01%
+10,841
New +$61.1K
PRLD icon
1237
Prelude Therapeutics
PRLD
$386M
$65.6K ﹤0.01%
13,846
-500
-3% -$1.95K
AUR icon
1238
Aurora
AUR
$13.6B
$65.4K ﹤0.01%
+23,180
New +$66.5K
ACET icon
1239
Adicet Bio
ACET
$74.9M
$65.4K ﹤0.01%
+1,738
New +$71.9K
LONA
1240
LeonaBio Inc
LONA
$71.6M
$64.8K ﹤0.01%
2,367
-775
-25% -$24.6K
SBSW icon
1241
Sibanye-Stillwater
SBSW
$7.54B
$64.4K ﹤0.01%
13,676
-308
-2% -$1.42K
CNDT icon
1242
Conduent
CNDT
$253M
$61.9K ﹤0.01%
+18,300
New +$63.5K
STRO icon
1243
Sutro Biopharma
STRO
$421M
$61.3K ﹤0.01%
1,086
-4,268
-80% -$189K
CMBM
1244
DELISTED
Cambium Networks
CMBM
$60.9K ﹤0.01%
14,135
-2,525
-15% -$11.4K
KVHI icon
1245
KVH Industries
KVHI
$152M
$59.7K ﹤0.01%
+11,702
New +$57.6K
PPSI
1246
Pioneer Power Solutions
PPSI
$33.1M
$58.7K ﹤0.01%
+10,283
New +$54.1K
RLGT icon
1247
Radiant Logistics
RLGT
$391M
$58.5K ﹤0.01%
10,800
-1,100
-9% -$6.53K
ITI
1248
DELISTED
Iteris, Inc.
ITI
$56.8K ﹤0.01%
11,500
+1,200
+12% +$5.93K
LYEL icon
1249
Lyell Immunopharma
LYEL
$349M
$56.4K ﹤0.01%
1,265
+390
+45% +$16.7K
DERM icon
1250
Journey Medical
DERM
$175M
$55.4K ﹤0.01%
+15,060
New +$65.5K
48 49
50
51 52

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Prelude Capital Management held 1,595 positions worth $1.91B, up 26% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management deployed $287M of net new capital in Q1 2024, opening 496 new positions and adding to 417 existing holdings. Its largest new stake was Mercury Systems: 206,337 shares worth $6.09M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was New Oriental, an estimated $14M trimmed.

  • Prelude Capital Management's largest Q1 2024 buy was Mercury Systems: 206,337 shares worth $6.09M.
  • Prelude Capital Management added most to Baidu in Q1 2024, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q1 2024 reduction was New Oriental, cutting an estimated $14M.
  • Prelude Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.91B portfolio in Q1 2024.
  • Prelude Capital Management opened 496 new positions and closed 313 in Q1 2024.
  • Prelude Capital Management's portfolio value rose 26% quarter-over-quarter to $1.91B.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.